PEPTIDE PRODUCTS
SOURCE OF YOUTH, HEALTH & BEAUTY
×
 x 

Cart empty
Shopping Cart
Cart empty

MITOTECH

mitotech

New possibilities opened up only in the beginning of this century. In 2004, a new substance was synthesized by the group of professor Vladimir P. Skulachev in the Moscow State University. Our project team later gave the substance its “production” name “SkQ1".

skq1

Two commercial entities Mitotech Russia and Mitotech EU were established around 2010 with an aim to develop SkQ1 into a drug targeting several age-related indications. Targeted therapeutic areas include ophthalmic and neurodegenerative disorders. The companies are running their clinical programs in different geographical markets with a common goal of making SkQ1-based drugs available to patients world-wide.

Research is Vladimir Petrovich Skulachev, biochemist, Academician of the Russian Academy of Sciences, Dean of the founding of the Faculty of Bioengineering and Bioinformatics, Moscow State University, and a team of about 100 professionals.

skulachev

THEORY: reactive oxygen species are known to present serious danger for living cells and whole organisms, especially with age.

TECHNOLOGY: SkQ1 reduces reactive oxygen species production inside mitochondria in a controlled and sustainable manner.

RESULTS: Several SkQ1-based drugs targeting various age-related disorders are being developed in our labs.

Contact Us

  • for questions about products
  • for questions about peptides
  • for questions about payment and delivery

contact-us

PLEASE
USE THE CONTACT FORM

or write to e-mail

email blue 2

Payments

payment footer2

  • PayPal is the faster, safer way to send money, make an online payment, receive money or set up a merchant account.
  • For those who have a Eurozone bank account we recommend to pay via bank transfer.
  • We accept payment by Revolut.

up gray